Posted May 25, 2018
San Francisco, CA (May 24) – TMS Health Solutions announced today that they have expanded their Union Square location focused exclusively on treating depression. They have now have built out an entire floor at 360 Post Street to increase access for their psychiatry services. “We realized there was a great need for more clinicians and treatment rooms,” said Richard Bermudes, Chief Medical Officer, “and are pleased to offer more services and appointments in downtown San Francisco for people who may need help.”
In total, there will be seven psychiatrists treating patients at the Union Square location, including three newer doctors who have joined the practice in the last six months. The new space includes two new transcranial magnetic stimulation (TMS) treatment rooms, which will allow the practice to help more patients with this innovative, non-medication treatment for depression, covered by most insurances.
Recent Clinicians Joining the Union Square Location:
Dr. Ferhad Ahmad is an Adolescent and Adult Psychiatrist who joined the practice in October, 2017. He completed his psychiatry residency at the Louisiana State University Health Sciences Center, where he also served at a Chief Fellow. With a collaborative approach in treating patients, he is highly skilled in pshychopharmacologic treatments and pleased to offer transcranial magnetic stimulation (TMS), which he sees as an instrument to medications in treating depression.
Dr. Yurik Dobry is a San Francisco native who most recently was the Medical Director of the UCSF Pediatric Mood and Anxiety Disorders Program. He is a Board-Certified Child, Adolescent and Adult Psychiatrist whose clinical focus is on patients with treatment-resistent depression and other mood discorders. With his experience in medication management and passion for helping patients, he is excited to use TMS to alleviate the taxing symptoms of depression. He joins the Union Square location in June of this year.
Dr. Nikhil Majumdar is Board-Certified in Psychiatry as well as in Addiction Medicine. He spent five years at the San Francisco VA Medical Center and was recently an attending psychiatrist at the Zuckerberg San Francisco General Hospital/University of California San Francisco. He considers TMS to be at the forefront of neurological and psychiatric treatment, and works with patients or may be experiencing clinical depression or other psychiatric disorders. He joins the Union Square location this coming July.
As depression and mental health continue to be topics of concern for society and with May being Mental Health Awarenss Month, TMS Health Solutions offers a unique, patient-centric experience and provides the most advanced therapies available for those suffering with mental health struggles and advanced depression.
About Transcranial Magnetic Stimulation (TMS) Therapy:
Cleared by the FDA in 2008, TMS is a drug-free, non-invasive therapy for patients who suffer from treatment-resistant depression. It is administered in a physician’s office in an outpatient setting. By using a MRI-strength magnetic field to stimulate the prefrontal cortex of the brain, the core symptoms of major depression can be relieved. Unlike antidepressants or Electroconvulsive Therapy (ECT), patients undergoing TMS therapy experience minimal side effects.
About TMS Health Solutions:
Headquartered in San Francisco, California, TMS Health Solutions clinics specialize in the delivery of TMS therapy for patients suffering from treatment-resistant depression. Additionally, the clinics provide traditional treatment for mood disorders. TMS Health Solutions is led by Dr. Richard Bermudes and Dr. Karl Lanocha, two of the nation’s leading experts on using TMS therapy as an innovative treatment for depression.